Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 13.25% is in line with its 5-year average of 14.22%, near the low end of its 5-year range (12.52%–23.32%).
As of the fiscal period ended Saturday, June 27, 2026. 1.99% above its 12-month average of 12.99%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-27): 13.25%.
RETURN ON EQUITY (ROE)
13.25%
RETURN ON EQUITY (ROE) AVG TTM
12.99%
RETURN ON EQUITY (ROE) AVG 3Y
12.99%
RETURN ON EQUITY (ROE) AVG 5Y
14.22%
RETURN ON EQUITY (ROE) AVG 10Y
12.68%
RETURN ON EQUITY (ROE) AVG 15Y
11.30%
RETURN ON EQUITY (ROE) AVG 20Y
9.81%
CURRENT VS TTM AVG
+1.99%
CURRENT VS 3Y AVG
+2.01%
CURRENT VS 5Y AVG
-6.82%
CURRENT VS 10Y AVG
+4.48%
CURRENT VS 15Y AVG
+17.27%
CURRENT VS 20Y AVG
+35.07%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+1.82%
vs the sector median at left
Thermo Fisher Scientific Inc.
Market Cap
$226.62B
Return on Equity (ROE)
13.25%
TTM Avg
12.99%
3Y Avg
12.99%
5Y Avg
14.22%
Market Cap
$248.40B
Return on Equity (ROE)
20.79%
TTM Avg
19.16%
3Y Avg
15.60%
5Y Avg
13.86%
Market Cap
$203.66B
Return on Equity (ROE)
74.80%
TTM Avg
79.33%
3Y Avg
111.35%
5Y Avg
101.76%
Market Cap
$191.26B
Return on Equity (ROE)
53.50%
TTM Avg
61.58%
3Y Avg
67.05%
5Y Avg
123.42%
Market Cap
$178.44B
Return on Equity (ROE)
-27.39%
TTM Avg
19.98%
3Y Avg
21.60%
5Y Avg
19.44%
Market Cap
$176.43B
Return on Equity (ROE)
10.61%
TTM Avg
20.32%
3Y Avg
18.59%
5Y Avg
17.97%
Market Cap
$157.99B
Return on Equity (ROE)
5.09%
TTM Avg
9.04%
3Y Avg
13.32%
5Y Avg
16.07%
Market Cap
$140.64B
Return on Equity (ROE)
7.61%
TTM Avg
7.38%
3Y Avg
9.51%
5Y Avg
10.24%
Market Cap
$130.82B
Return on Equity (ROE)
21.76%
TTM Avg
8.96%
3Y Avg
15.60%
5Y Avg
19.47%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $226.62B | 13.25% | 12.99% | 12.99% | 14.22% |
| AstraZeneca PLC (AZN)vs › | $248.40B | 20.79% | 19.16% | 15.60% | 13.86% |
| Amgen Inc. (AMGN)vs › | $203.66B | 74.80% | 79.33% | 111.35% | 101.76% |
| Novo Nordisk A/S (NVO)vs › | $191.26B | 53.50% | 61.58% | 67.05% | 123.42% |
| Gilead Sciences, Inc. (GILD)vs › | $178.44B | -27.39% | 19.98% | 21.60% | 19.44% |
| Abbott Laboratories (ABT)vs › | $176.43B | 10.61% | 20.32% | 18.59% | 17.97% |
| Pfizer Inc. (PFE)vs › | $157.99B | 5.09% | 9.04% | 13.32% | 16.07% |
| Danaher Corporation (DHR)vs › | $140.64B | 7.61% | 7.38% | 9.51% | 10.24% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.82B | 21.76% | 8.96% | 15.60% | 19.47% |
| Intuitive Surgical, Inc. (ISRG)vs › | $130.41B | 17.28% | 15.07% | 13.91% | 13.46% |
ROE
13.2%
ROA
6.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-27 | 13.25% |
| 2026-03-28 | 13.21% |
| 2025-12-31 | 12.57% |
| 2025-09-27 | 12.88% |
| 2025-06-28 | 13.03% |
| 2025-03-29 | 13.19% |
| 2024-12-31 | 12.78% |
| 2024-09-28 | 12.52% |
| 2024-06-29 | 13.12% |
| 2024-03-30 | 13.26% |
| 2023-12-31 | 12.83% |
| 2023-09-30 | 13.11% |
| 2023-07-01 | 13.08% |
| 2023-04-01 | 14.26% |
| 2022-12-31 | 15.80% |
| 2022-10-01 | 16.15% |
| 2022-07-02 | 17.59% |
| 2022-04-02 | 18.56% |
| 2021-12-31 | 18.94% |
| 2021-10-02 | 22.13% |
| 2021-07-03 | 23.32% |
| 2021-04-03 | 22.60% |
| 2020-12-31 | 18.47% |
| 2020-09-26 | 15.33% |
| 2020-06-27 | 12.41% |
| 2020-03-28 | 12.85% |
| 2019-12-31 | 12.45% |
| 2019-09-28 | 12.24% |
| 2019-06-29 | 12.33% |
| 2019-03-30 | 11.46% |
| 2018-12-31 | 10.65% |
| 2018-09-29 | 9.55% |
| 2018-06-30 | 9.05% |
| 2018-03-31 | 8.62% |
| 2017-12-31 | 8.76% |
| 2017-09-30 | 9.42% |
| 2017-07-01 | 10.12% |
| 2017-04-01 | 9.96% |
| 2016-12-31 | 9.39% |
| 2016-10-01 | 9.21% |
| 2016-07-02 | 9.39% |
| 2016-04-02 | 9.52% |
| 2015-12-31 | 9.25% |
| 2015-09-26 | 9.47% |
| 2015-06-27 | 9.52% |
| 2015-03-28 | 8.72% |
| 2014-12-31 | 9.22% |
| 2014-09-27 | 7.97% |
| 2014-06-28 | 7.17% |
| 2014-03-29 | 7.25% |
| 2013-12-31 | 7.55% |
| 2013-09-28 | 7.96% |
| 2013-06-29 | 8.10% |
| 2013-03-30 | 7.93% |
| 2012-12-31 | 7.62% |
| 2012-09-29 | 14.01% |
| 2012-06-30 | 7.06% |
| 2012-03-31 | 8.86% |
| 2011-12-31 | 8.84% |
| 2011-10-01 | 8.81% |
| 2011-07-02 | 8.56% |
| 2011-04-02 | 6.92% |
| 2010-12-31 | 6.74% |
| 2010-10-02 | 6.57% |
| 2010-07-03 | 6.28% |
| 2010-04-03 | 6.03% |
| 2009-12-31 | 5.51% |
| 2009-09-26 | 5.63% |
| 2009-06-27 | 5.73% |
| 2009-03-31 | 6.05% |
| 2008-12-31 | 6.64% |
| 2008-09-27 | 6.21% |
| 2008-06-28 | 6.24% |
| 2008-03-29 | 5.78% |
| 2007-12-31 | 5.25% |
| 2007-09-29 | 3.78% |
| 2007-06-30 | 2.59% |
| 2007-03-31 | 1.83% |
| 2006-12-31 | 1.21% |
| 2006-09-30 | 7.10% |
| 2006-07-01 | 7.63% |
| 2006-04-01 | 7.70% |
| 2005-12-31 | 7.99% |
| 2005-10-01 | 10.43% |
| 2005-07-02 | 12.54% |
| 2005-04-02 | 13.77% |
| 2004-12-31 | 13.61% |
| 2004-10-02 | 12.50% |
| 2004-07-03 | 9.97% |
| 2004-04-03 | 8.52% |
| 2003-12-31 | 8.39% |
| 2003-09-27 | 10.08% |
| 2003-06-28 | 9.86% |
